Immune Imbalance in the Gut May Trigger Celiac Disease

Source:

HospiMedica International staff writers

http://www.hospimedica.com/?option=com_article&Itemid=294733577&cat=Critical+Care&ui=1960149838&vrf=3ef5d7cad7e81077c42186fce74ceed6&end=%2520

A new study claims that people who have high levels of Interleukin-15 may be primed to develop celiac disease (CD), a digestive disorder that keeps sufferers from eating foods like cereal, pasta, cookies, and beer.

Fluorescent Peptides Make Nerves Glow During Surgery

 Image: NP41 highlighting buried nerve branches invisible by standard illumination (photo courtesy University of California, San Diego).

Source:

HospiMedica International staff writers

http://www.hospimedica.com/?option=com_article&Itemid=294733579&cat=Surgical+Techniques&ui=1960149838&vrf=3ef5d7cad7e81077c42186fce74ceed6&end=%2520

Injectable fluorescent peptides that cause hard-to-see peripheral nerves to glow could alert surgeons to their location, even before the nerves are encountered.

The Importance of a Heart Smart Diet

There are many things that contribute to or undermine the health of your heart. Some factors you can't control, such as your age, sex, race, and family history of heart disease. However, there are plenty that you do have control over, like stopping smoking, reducing stress, losing weight if you're overweight, exercising regularly, and eating a heart-smart diet. If you care about enjoying a healthy life for a long time to come, you need to take action on some of the things that you can control:

CPAP Therapy Reduces Fatigue in Patients with Sleep Apnea

Source:

http://www.hospimedica.com/critical_care/articles/294732947/cpap_therapy_reduces_fatigue_in_patients_with_sleep_apnea.html

HospiMedica International staff writers

Posted on 13 Jan 2011

Three weeks of continuous positive airway pressure (CPAP) therapy significantly reduced fatigue and increased energy in patients with obstructive sleep apnea (OSA), according to a new study.

Researchers at San Diego State University (SDSU; CA, USA) and the University of California San Diego (UCSD; USA) conducted a double-blind study which randomly assigned 59 men and women with OSA to therapeutic or placebo CPAP for a 3-week intervention period. The researchers assessed four outcome measures; fatigue/vigor measured with the Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-sf); both fatigue and vigor subscales of the Profile of Mood States-Short Form (POMS); and the Epworth Sleepiness Scale (ESS). Questionnaire data were obtained prior to study randomization and after the three-week intervention period.